Fig. 1. Anti-A isoagglutinin titers of recipient with plasmapheresis and rituximab administration. PP, plasmapheresis; POD, postoperative day.

Korean J Transplant 2022;36:67~72 https://doi.org/10.4285/kjt.21.0027